Annual CFO
-$43.06 M
-$7.91 M-22.50%
31 December 2023
Summary:
Acumen Pharmaceuticals annual cash flow from operations is currently -$43.06 million, with the most recent change of -$7.91 million (-22.50%) on 31 December 2023. During the last 3 years, it has fallen by -$35.61 million (-478.04%). ABOS annual CFO is now -531.62% below its all-time high of -$6.82 million, reached on 31 December 2019.ABOS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$24.60 M
-$8.05 M-48.66%
30 September 2024
Summary:
Acumen Pharmaceuticals quarterly cash flow from operations is currently -$24.60 million, with the most recent change of -$8.05 million (-48.66%) on 30 September 2024. Over the past year, it has dropped by -$11.69 million (-90.59%). ABOS quarterly CFO is now -1817.07% below its all-time high of -$1.28 million, reached on 30 September 2020.ABOS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$67.31 M
-$11.69 M-21.02%
30 September 2024
Summary:
Acumen Pharmaceuticals TTM cash flow from operations is currently -$67.31 million, with the most recent change of -$11.69 million (-21.02%) on 30 September 2024. Over the past year, it has dropped by -$21.36 million (-46.48%). ABOS TTM CFO is now -3606.72% below its all-time high of -$1.82 million, reached on 31 March 2020.ABOS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABOS Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.5% | -90.6% | -46.5% |
| 3 y3 years | -478.0% | -219.9% | -291.8% |
| 5 y5 years | - | - | - |
ABOS Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -478.0% | at low | -575.9% | at low | -291.8% | at low |
| 5 y | 5 years | -531.6% | at low | -1817.1% | at low | -3606.7% | at low |
| alltime | all time | -531.6% | at low | -1817.1% | at low | -3606.7% | at low |
Acumen Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.60 M(+48.7%) | -$67.31 M(+21.0%) |
| June 2024 | - | -$16.55 M(-7.4%) | -$55.62 M(+9.6%) |
| Mar 2024 | - | -$17.86 M(+114.8%) | -$50.75 M(+17.8%) |
| Dec 2023 | -$43.06 M(+22.5%) | -$8.31 M(-35.6%) | -$43.06 M(-6.3%) |
| Sept 2023 | - | -$12.90 M(+10.6%) | -$45.95 M(+8.8%) |
| June 2023 | - | -$11.67 M(+14.7%) | -$42.23 M(+14.0%) |
| Mar 2023 | - | -$10.18 M(-9.2%) | -$37.03 M(+5.3%) |
| Dec 2022 | -$35.15 M | -$11.20 M(+22.0%) | -$35.15 M(+27.4%) |
| Sept 2022 | - | -$9.18 M(+42.0%) | -$27.59 M(+5.7%) |
| June 2022 | - | -$6.47 M(-22.1%) | -$26.09 M(+9.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$8.30 M(+128.1%) | -$23.89 M(+33.0%) |
| Dec 2021 | -$17.96 M(+141.1%) | -$3.64 M(-52.7%) | -$17.96 M(+4.6%) |
| Sept 2021 | - | -$7.69 M(+80.3%) | -$17.18 M(+59.4%) |
| June 2021 | - | -$4.26 M(+79.9%) | -$10.77 M(+34.6%) |
| Mar 2021 | - | -$2.37 M(-17.0%) | -$8.00 M(+7.4%) |
| Dec 2020 | -$7.45 M(+9.3%) | - | - |
| Dec 2020 | - | -$2.86 M(+122.7%) | -$7.45 M(+62.2%) |
| Sept 2020 | - | -$1.28 M(-14.1%) | -$4.59 M(+38.8%) |
| June 2020 | - | -$1.49 M(-17.7%) | -$3.31 M(+82.3%) |
| Mar 2020 | - | -$1.82 M | -$1.82 M |
| Dec 2019 | -$6.82 M | - | - |
FAQ
- What is Acumen Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals annual CFO year-on-year change?
- What is Acumen Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals quarterly CFO year-on-year change?
- What is Acumen Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals TTM CFO year-on-year change?
What is Acumen Pharmaceuticals annual cash flow from operations?
The current annual CFO of ABOS is -$43.06 M
What is the all time high annual CFO for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high annual cash flow from operations is -$6.82 M
What is Acumen Pharmaceuticals annual CFO year-on-year change?
Over the past year, ABOS annual cash flow from operations has changed by -$7.91 M (-22.50%)
What is Acumen Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ABOS is -$24.60 M
What is the all time high quarterly CFO for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high quarterly cash flow from operations is -$1.28 M
What is Acumen Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ABOS quarterly cash flow from operations has changed by -$11.69 M (-90.59%)
What is Acumen Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ABOS is -$67.31 M
What is the all time high TTM CFO for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high TTM cash flow from operations is -$1.82 M
What is Acumen Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ABOS TTM cash flow from operations has changed by -$21.36 M (-46.48%)